Novel benzopyran derivatives and their therapeutic applications: a patent review (2009-2016).

about

Novel benzopyran derivatives and their therapeutic applications: a patent review (2009-2016).

Item

http://www.wikidata.org/entity/Q39382164

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Novel benzopyran derivatives a ...... : a patent review (2009-2016).

@en

Novel benzopyran derivatives and their therapeutic applications: a patent review

@nl

type

Item

label

Novel benzopyran derivatives a ...... : a patent review (2009-2016).

@en

Novel benzopyran derivatives and their therapeutic applications: a patent review

@nl

prefLabel

Novel benzopyran derivatives a ...... : a patent review (2009-2016).

@en

Novel benzopyran derivatives and their therapeutic applications: a patent review

@nl

P1476

Novel benzopyran derivatives a ...... : a patent review (2009-2016).

@en

P2093

Bao Sheng Xiao

http://www.w3.org/2001/XMLSchema#string

Cheng Xiu

http://www.w3.org/2001/XMLSchema#string

Hai Pin Zhou

http://www.w3.org/2001/XMLSchema#string

Wen Jian Tang

http://www.w3.org/2001/XMLSchema#string

Xin Hua Liu

http://www.w3.org/2001/XMLSchema#string

Zhou Hua

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting androgen receptor and JunD interaction for prevention of prostate cancer progression

CYP1B1-mediated Pathobiology of Primary Congenital Glaucoma

KLK5 Inactivation Reverses Cutaneous Hallmarks of Netherton Syndrome

The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: the second clinical candidate having a shorter and favorable human half-life

Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP

Gastrointestinal-related complications in a long-term care population taking NSAIDs versus COX-2 inhibitor therapy

Disposition of docetaxel in the presence of P-glycoprotein inhibition by intravenous administration of R101933.

Structure of the Sulfolobus solfataricus alpha-glucosidase: implications for domain conservation and substrate recognition in GH31.

Androgen receptor requires JunD as a coactivator to switch on an oxidative stress generation pathway in prostate cancer cells.

A Review on the Relationship between SGLT2 Inhibitors and Cancer.

P304

1031-1045

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13543776.2017.1338687

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28627270

http://www.w3.org/2001/XMLSchema#string